Timely Data Resources | 9 pages | December 2006 | English
The Non-Small Cell Lung Cancer (NSCLC) Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis and staging, and an ...
In 2007, the world market for bone metabolism disorder pharmaceuticals generated sales of over $10bn - how much of this market have you captured?The majority of this market consists of the fast-expand ...
IBISWORLD INDUSTRY MARKET RESEARCH REPORTThis is the replacement for IBISWorld's November 2007 edition of Pharmaceutical & Medicine Manufacturing in the US report.Industry Market Research SynopsisThis ...
The metrics in this report cover three year trends in Tablets, pharmaceutical [Manufacturing sector], broken out on a state-by-state basis. Analysis is based on data applied from 17 industry firms. ...
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the cancer therapeutic area. MarketWatch features all the ...
Datamonitor's Bellco Health - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the companys key business structure and operati ...
IntroductionNon-Hodgkin's lymphoma (NHL) is the most common hematological malignancy and is comprised of around 30 different disease subtypes. Each of these present with a distinct set histological ...
Global Industry Analyst | 409 pages | May 2008 | English
This report analyzes the worldwide markets for Veterinary Vaccines in US$ Million. The specific product segments analyzed are Companion Animal Vaccines (Canine Vaccines, & Feline Vaccines), and Liv ...
Snapshots International | 13 pages | October 2005 | English
Snapdata's China Pharmaceuticals 2005 report provides 2004 year-end market data, with 2005 estimates and five-year forecasts. The report gives an instant overview of the Chinese pharmaceutical mark ...
IntroductionThis analysis examines the historical and forecast performance for Cephalon in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline ...